Northeast Financial Consultants’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,312
Closed -$213K 282
2024
Q4
$213K Hold
1,312
0.01% 273
2024
Q3
$214K Buy
+1,312
New +$194K 0.01% 276
2024
Q2
Sell
-1,312
Closed -$201K 277
2024
Q1
$201K Buy
+1,312
New +$196K 0.01% 274
2023
Q3
Sell
-1,312
Closed -$209K 288
2023
Q2
$209K Hold
1,312
0.01% 267
2023
Q1
$208K Buy
+1,312
New +$197K 0.01% 293
2022
Q1
Sell
-1,312
Closed -$229K 392
2021
Q4
$229K Buy
+1,312
New +$219K 0.01% 319
2021
Q1
Sell
-1,000
Closed -$202K 332
2020
Q4
$202K Hold
1,000
0.02% 306
2020
Q3
$210K Sell
1,000
-12
-1% -$2.67K 0.02% 276
2020
Q2
$222K Buy
+1,012
New +$202K 0.02% 258
2018
Q2
Sell
-3,600
Closed -$479K 147
2018
Q1
$479K Hold
3,600
0.16% 91
2017
Q4
$535K Hold
3,600
0.18% 87
2017
Q3
$475K Buy
+3,600
New +$484K 0.17% 91

Other funds holding CLX

Northeast Financial Consultants's CLX Position: Q1 2025 in Review

Northeast Financial Consultants sold out of Clorox (CLX) in Q1 2025, closing a stake of 1,312 shares — an estimated $213K sold.

Northeast Financial Consultants first reported a position in CLX in Q3 2017 and held it in 12 quarters. The position peaked at $535K in Q4 2017. 1,186 funds tracked by Wall St. Rank hold CLX as of Q1 2025.

  • Northeast Financial Consultants reported no remaining Clorox position as of Q1 2025 after selling out during the quarter.
  • Northeast Financial Consultants sold 1,312 Clorox shares in Q1 2025, an estimated $213K.
  • Northeast Financial Consultants first reported a position in Clorox in Q3 2017 and held it in 12 quarters.
  • Northeast Financial Consultants's Clorox position peaked at $535K in Q4 2017.
  • 1,186 funds tracked by Wall St. Rank held Clorox as of Q1 2025.

Based on Northeast Financial Consultants's 13F filing for Q1 2025, filed 16 May 2025.